Tiny study to test if morphine in pain pumps goes bad
NCT ID NCT07641608
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at morphine taken from implanted pain pumps in 5 adults with chronic pain. Researchers want to see if the drug stays sterile and chemically stable after 3 to 6 months inside the pump. The goal is to learn more about real-world safety, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 5 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2027
An estimate. Start dates often move.
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients (age ≥ 18 years), Diagnosed with chronic pain and currently treated with an implantable intrathecal pump, receiving intrathecal Morphine (Rafa Laboratories, 20 mg/ml; registration no. 106-25-28981-00), scheduled for a routine pump refill procedure at an interval of 3 to 6 months..
- Ages
-
18 to 99 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: • Adult patients (age ≥ 18 years), Diagnosed with chronic pain and currently treated with an implantable intrathecal pump. * Receiving intrathecal Morphine (Rafa Laboratories, 20 mg/ml; registration no. 106-25-28981-00). * Scheduled for a routine pump refill procedure at an interval of 3 to 6 months. Exclusion Criteria:• Patients receiving polyanalgesic mixtures (admixtures of morphine with other drugs) in the intrathecal pump. * Evidence of active systemic infection or localized infection at the pump implantation site. * History of recent pump malfunction or refills occurring outside the standard 3 to 6-month window. * Inability to provide informed consent. * Pregnant patients.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Rate of positive culture from morphine aspirate are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Meir Medical Center
Kfar Saba, Israel